INDSWFTLAB

Ind-Swift Laboratories Limited

Pharmaceuticals · ₹2,044 Cr market cap

A pharmaceutical manufacturer engaged in the production of bulk drugs and formulations, Ind-Swift Laboratories operates across India's medicinal compounds sector. Established in 1995, the company focuses on developing and supplying active pharmaceutical ingredients and finished dosage forms to both domestic and international markets. Its integrated operations span research, manufacturing, quality control, and distribution within the broader pharmaceutical value chain.

0
Tracked investors holding
2
Tracked moves
236
Share price

Latest activity

Sahastraa AdvisorsNew position
Sahastraa Advisors bought 4,75,000 shares of Ind-Swift Laboratories for ₹6.26 Cr at ₹131.74 apiece in a bulk deal on April 17, 2026.
17 Apr 2026

Track smart money in Ind-Swift Laboratories Limited

Get alerted when a top investor buys or sells.

Get started